Report test results requires vigilance

July 2009
Healthcare Risk Management;Jul2009, Vol. 31 Issue 7, p76
The article reports on the need of right policies and procedures for the healthcare professionals because it will provide guidelines on how to handle critical results of the medical tests in the U.S.


Related Articles

  • New Rule: Individuals Can Get Test Results from Labs.  // Health Data Management;Nov2011, Vol. 19 Issue 11, p19 

    The article focuses on a proposed rule issued by the U.S. Centers for Medicare and Medicaid Services (CMS) which would enable patients to electronically access their laboratory test results directly from labs.

  • FDA OKs first over-the-counter home-use HIV test kit.  // Windy City Times;7/11/2012, Vol. 27 Issue 38, p6 

    The article reports on the approval given by the U.S. Food and Drug Administration (FDA) to the OraQuick In-Home HIV Test, the first over-the-counter, self-administered HIV test kit.

  • Molecular Diagnostics Educational Partnership: A Model for Universities, Community Colleges and Industry. Zimmerman, Gregory R. // Annual Global Healthcare Conference;2013, p73 

    The field of laboratory medicine is advancing towards the use of molecular techniques and molecular diagnostics for the detection of genetic disorders, infectious diseases and cancers. These same techniques are greatly enhancing pre-transplantation screening as well. In addition, the...

  • Newborn Screening for Severe Combined Immunodeficiency. Holtzman, Neil A. // JAMA: Journal of the American Medical Association;8/20/2014, Vol. 312 Issue 7, p701 

    The author comments on a report by Kwan and colleagues about the newborn screening for severe combined immunodeficiency (SCID) that has been conducted in 23 U.S. states and the Navajo Nation. Topics discussed include the suggested diagnosis, prognosis, and treatment options for SCID, and the...

  • Four Q&As Help You Fall in Line With Heart Disease Screening Criteria.  // Part B Insider;4/12/2010, Vol. 11 Issue 13, p102 

    The article focuses on the cardiovascular screening test being offered to all eligible Medicare beneficiaries in the U.S. It notes that one is eligible for the heart disease screening test if one has not had the test in the last five years and one must manifest no signs or symptoms of...

  • CMS Revisits the Diagnostic Test Anti-Markup Rule.  // Venulex Legal Summaries;2008 Q3, Special section p1 

    The article looks at the changes to the Medicare diagnostic test anti-markup rule made by the U.S. Centers for Medicare and Medicaid Services (CMS) in its final 2008 Medicare Physician Fee Schedule (MPFS) rule. The Anti-Markup Rule has been extended by CMS to the professional component of...

  • Health Policy and Diabetes Care: Is It Time to Put Politics Aside? Herman, William H.; Cefalu, William T. // Diabetes Care;May2015, Vol. 38 Issue 5, p743 

    The article discusses the need for U.S. politicians to come up with effective policies to address chronic diseases across the country, where diabetes is said to cost 245 billion U.S. dollars as of 2012. Topics discussed include benefits associated with having specific targets when creating...

  • Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database. Williams, James R.; Fitzhenry, David; Grant, Lauren; Martyn, Derek; Kerr, Douglas A. // BMC Neurology;2013, Vol. 13 Issue 1, p1 

    Background Initial symptoms of amyotrophic lateral sclerosis (ALS) are often subtle and can delay diagnosis. This exploratory analysis was conducted to better characterize the pre-diagnosis pathway undertaken by patients with ALS in the US Centers for Medicare & Medicaid Services Medicare...

  • Introduction. Stevens, Rosemary A. // History & Health Policy in the United States;2006, p1 

    An introduction to the book is presented in which the author discusses the goals of the book, the essays that presents historical messages concerning the healthcare system in the U.S., and the extraordinary interplay of public and private actors and actions in American health policy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics